Physical activity counteracts increased whole-body protein breakdown in chronic obstructive pulmonary disease patients

Scandinavian Journal of Medicine and Science in Sports

Volumn 18, Issue 5, 2008, Pages 557-564

  Petersen, A M W ^a,b,e   Mittendorfer, B ^c   Magkos, F ^c   Iversen, M ^d   Pedersen, B K ^a,b  

^a Centre of Inflammation and Metabolism   (United States)

^b Copenhagen Muscle Research Centre ^*  (United States)

^c WASHINGTON UNIVERSITY   (United States)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e Rigshospitalet   (Denmark)

Author keywords

Cytokines; Physical training; Protein turnover; Respiratory disease

Indexed keywords

AUTACOID; C REACTIVE PROTEIN; INTERLEUKIN 18; LEUCINE;

AGED; ARTICLE; BLOOD; BODY COMPOSITION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDURANCE; EXERCISE TOLERANCE; FEMALE; HUMAN; KINESIOTHERAPY; LUNG FUNCTION TEST; MALE; MIDDLE AGED; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL;

AGED; BODY COMPOSITION; C-REACTIVE PROTEIN; EXERCISE THERAPY; EXERCISE TOLERANCE; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-18; LEUCINE; MALE; MIDDLE AGED; PHYSICAL ENDURANCE; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RESPIRATORY FUNCTION TESTS;

EID: 52249120792     PISSN: 09057188     EISSN: 16000838     Source Type: Journal    
DOI: 10.1111/j.1600-0838.2007.00727.x     Document Type: Article

References (51)

1. Abramson JL, Vaccarino V. Relationship between physical activity and inflammation among apparently healthy middle-aged and older US adults. Arch Intern Med 2002 : 162 : 1286 1292.
2. Anker SD, Coats AJ. Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation. Chest 1999 : 115 : 836 847.
3. Baarends EM, Schols AM, Mostert R, Wouters EF. Peak exercise response in relation to tissue depletion in patients with chronic obstructive pulmonary disease. Eur Respir J 1997 : 10 : 2807 2813.
4. Babraj J, Cuthbertson DJ, Rickhuss P, Meier-Augenstein W, Smith K, Bohe J, Wolfe RR, Gibson JN, Adams C, Rennie MJ. Sequential extracts of human bone show differing collagen synthetic rates. Biochem Soc Trans 2002 : 30 : 61 65.
5. Bruunsgaard H, Ladelund S, Pedersen AN, Schroll M, Jorgensen T, Pedersen BK. Predicting death from tumour necrosis factor-alpha and interleukin-6 in 80-year-old people. Clin Exp Immunol 2003 : 132 : 24 31.
6. Carr A, Emery S, Law M, Puls R, Lundgren JD, Powderly WG. An objective case definition of lipodystrophy in HIV-infected adults: a case-control study. Lancet 2003 : 361 : 726 735.
7. Chinkes D, Klein S, Zhang XJ, Wolfe RR. Infusion of labeled KIC is more accurate than labeled leucine to determine human muscle protein synthesis. Am J Physiol 1996 : 270 : E67 E71.
8. de Godoy I, Donahoe M, Calhoun WJ, Mancino J, Rogers RM. Elevated TNF-alpha production by peripheral blood monocytes of weight-losing COPD patients. Am J Respir Crit Care Med 1996 : 153 : 633 637.
9. Debigare R, Cote CH, Maltais F. Peripheral muscle wasting in chronic obstructive pulmonary disease. Clinical relevance and mechanisms. Am J Respir Crit Care Med 2001 : 164 : 1712 1717.
10. Di Francia M, Barbier D, Mege JL, Orehek J. Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994 : 150 : 1453 1455.
11. Engelen MP, Deutz NE, Wouters EF, Schols AM. Enhanced levels of whole-body protein turnover in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000a : 162 : 1488 1492.
12. Engelen MP, Schols AM, Baken WC, Wesseling GJ, Wouters EF. Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPD. Eur Respir J 1994 : 7 : 1793 1797.
13. Engelen MP, Schols AM, Does JD, Wouters EF. Skeletal muscle weakness is associated with wasting of extremity fat-free mass but not with airflow obstruction in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 2000b : 71 : 733 738.
14. European Respiratory Society. Standardised lung function testing: official statement of the European Respiratory Society. Eur Respir J 2003 : 6 : 1 100.
15. Fallon KE, Fallon SK, Boston T. The acute phase response and exercise: court and field sports. Br J Sports Med 2001 : 35 : 170 173.
16. Febbraio MA, Pedersen BK. Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. FASEB J 2002 : 16 : 1335 1347.
17. Geffken DF, Cushman M, Burke GL, Polak JF, Sakkinen PA, Tracy RP. Association between physical activity and markers of inflammation in a healthy elderly population. Am J Epidemiol 2001 : 153 : 242 250.
18. Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 1996 : 153 : 976 980.
19. Hartman JW, Moore DR, Phillips SM. Resistance training reduces whole-body protein turnover and improves net protein retention in untrained young males. Appl Physiol Nutr Metab 2006 : 31 : 557 564.
20. Higham MA, Pride NB, Alikhan A, Morrell NW. Tumour necrosis factor-alpha gene promoter polymorphism in chronic obstructive pulmonary disease. Eur Respir J 2000 : 15 : 281 284.
21. Jagoe RT, Engelen MP. Muscle wasting and changes in muscle protein metabolism in chronic obstructive pulmonary disease. Eur Respir J 2003 : 46 (Suppl.) : 52s 63s.
22. Jones PW, Quirk FH, Baveystock CM. The St George's respiratory questionnaire. Respir Med 1991 : 85 (Suppl. B) : 25 31 discussion 33-37., 25-31.
23. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992 : 145 : 1321 1327.
24. King DE, Carek P, Mainous AG III., Pearson WS. Inflammatory markers and exercise: differences related to exercise type. Med Sci Sports Exerc 2003 : 35 : 575 581.
25. Kobayashi A, Yoneda T, Yoshikawa M, Ikuno M, Takenaka H, Fukuoka A, Narita N, Nezu K. The relation of fat-free mass to maximum exercise performance in patients with chronic obstructive pulmonary disease. Lung 2000 : 178 : 119 127.
26. Kujala UM. Evidence for exercise therapy in the treatment of chronic disease based on at least three randomized controlled trials - summary of published systematic reviews. Scand J Med Sci Sports 2004 : 14 : 339 345.
27. Lacasse Y, Brosseau L, Milne S, Martin S, Wong E, Guyatt GH, Goldstein RS. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2002 : 3 : CD003793.
28. Marquis K, Debigare R, Lacasse Y, LeBlanc P, Jobin J, Carrier G, Maltais F. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002 : 166 : 809 813.
29. Matthews DE, Schwarz HP, Yang RD, Motil KJ, Young VR, Bier DM. Relationship of plasma leucine and alpha-ketoisocaproate during a L-[1-13C]leucine infusion in man: a method for measuring human intracellular leucine tracer enrichment. Metabolism 1982 : 31 : 1105 1112.
30. Mattusch F, Dufaux B, Heine O, Mertens I, Rost R. Reduction of the plasma concentration of C-reactive protein following nine months of endurance training. Int J Sports Med 2000 : 21 : 21 24.
31. Morrison WL, Gibson JN, Scrimgeour C, Rennie MJ. Muscle wasting in emphysema. Clin Sci (London) 1988 : 75 : 415 420.
32. Mostert R, Goris A, Weling-Scheepers C, Wouters EF, Schols AM. Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease. Respir Med 2000 : 94 : 859 867.
33. Noble BJ. Clinical applications of perceived exertion. Med Sci Sports Exerc 1982 : 14 : 406 411.
34. Pauwels RA, Buist AS, Ma P, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. Respir Care 2001 : 46 : 798 825.
35. Pedersen BK, Hoffman-Goetz L. Exercise and the immune system: regulation, integration and adaption. Physiol Rev 2000 : 80 : 1055 1081.
36. Pedersen BK, Saltin B. Evidence for prescribing exercise as therapy in chronic disease. Scand J Med Sci Sports 2006 : 16 (Suppl. 1) : 3 63.
37. Pedersen BK, Steensberg A, Schjerling P. Muscle-derived interleukin-6: possible biological effects. J Physiol (London) 2001 : 536 : 329 337.
38. Reeds DN, Cade WT, Patterson BW, Powderly WG, Klein S, Yarasheski KE. Whole-body proteolysis rate is elevated in HIV-associated insulin resistance. Diabetes 2006 : 55 : 2849 2855.
39. Revill SM, Morgan MD, Singh SJ, Williams J, Hardman AE. The endurance shuttle walk: a new field test for the assessment of endurance capacity in chronic obstructive pulmonary disease. Thorax 1999 : 54 : 213 222.
40. Rutten EP, Franssen FM, Engelen MP, Wouters EF, Deutz NE, Schols AM. Greater whole-body myofibrillar protein breakdown in cachectic patients with chronic obstructive pulmonary disease. Am J Clin Nutr 2006 : 83 : 829 834.
41. Salman GF, Mosier MC, Beasley BW, Calkins DR. Rehabilitation for patients with chronic obstructive pulmonary disease: meta-analysis of randomized controlled trials. J Gen Intern Med 2003 : 18 : 213 221.
42. Schols AM, Buurman WA, Staal van den Brekel AJ, Dentener MA, Wouters EF. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax 1996 : 51 : 819 824.
43. Schols AM, Slangen J, Volovics L, Wouters EF. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998 : 157 : 1791 1797.
44. Schols AM, Soeters PB, Dingemans AM, Mostert R, Frantzen PJ, Wouters EF. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis 1993 : 147 : 1151 1156.
45. Schwenk WF, Berg PJ, Beaufrere B, Miles JM, Haymond MW. Use of t-butyldimethylsilylation in the gas chromatographic/mass spectrometric analysis of physiologic compounds found in plasma using electron-impact ionization. Anal Biochem 1984 : 141 : 101 109.
46. Singh SJ, Morgan MD, Hardman AE, Rowe C, Bardsley PA. Comparison of oxygen uptake during a conventional treadmill test and the shuttle walking test in chronic airflow limitation. Eur Respir J 1994 : 7 : 2016 2020.
47. Smith JK, Dykes R, Douglas JE, Krishnaswamy G, Berk S. Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart disease. JAMA 1999 : 281 : 1722 1727.
48. Suzuki K, Nakaji S, Yamada M, Totsuka M, Sato K, Sugawara K. Systemic inflammatory response to exhaustive exercise. Cytokine kinetics. Exerc Immunol Rev 2002 : 8 : 6 48.
49. Taaffe DR, Harris TB, Ferrucci L, Rowe J, Seeman TE. Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons: MacArthur studies of successful aging. J Gerontol A Biol Sci Med Sci 2000 : 55 : M709 M715.
50. Tisi PV, Hulse M, Chulakadabba A, Gosling P, Shearman CP. Exercise training for intermittent claudication: does it adversely affect biochemical markers of the exercise-induced inflammatory response? Eur J Vasc Endovasc Surg 1997 : 14 : 344 350.
51. Wannamethee SG, Lowe GD, Whincup PH, Rumley A, Walker M, Lennon L. Physical activity and hemostatic and inflammatory variables in elderly men. Circulation 2002 : 105 : 1785 1790.